Kester Kent Edward bought TTRX
June 4, 2026 · Form 4 insider transaction
Kester Kent Edward bought 83,334 shares of Turn Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
83,334
Price
$0.00
Total value
N/A
InsiderKester Kent Edward
Role—
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after83,334
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest in twelve (12) equal monthly installments, on the last day of each calendar month, commencing on June 30, 2026, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan.